CB
DFTX

CNB Bank’s Definium Therapeutics DFTX Stock Holding History

CNB Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10
Closed -$134 – 529
2025
Q4 		$134 Hold
10
– – ﹤0.01% 503
2025
Q3 		$118 Hold
10
– – ﹤0.01% 501
2025
Q2 		$65 Hold
10
– – ﹤0.01% 499
2025
Q1 		$59 Hold
10
– – ﹤0.01% 488
2024
Q4 		$70 Hold
10
– – ﹤0.01% 495
2024
Q3 		$57 Hold
10
– – ﹤0.01% 522
2024
Q2 		$72 Hold
10
– – ﹤0.01% 506
2024
Q1 		$94 Hold
10
– – ﹤0.01% 492
2023
Q4 		$37 Hold
10
– – ﹤0.01% 481
2023
Q3 		$31 Hold
10
– – ﹤0.01% 492
2023
Q2 		$36 Hold
10
– – ﹤0.01% 441
2023
Q1 		$32 Hold
10
– – ﹤0.01% 480
2022
Q4 		$22 Buy
+10
New +$28 ﹤0.01% 457
2022
Q3 		– Sell
-10
Closed – – 478
2022
Q2 		$0 Buy
+10
New +$127 ﹤0.01% 498
2022
Q1 		– Sell
-10
Closed – – 516
2021
Q4 		$0 Hold
10
– – ﹤0.01% 479
2021
Q3 		$1K Buy
+10
New +$432 ﹤0.01% 402

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CNB Bank's DFTX Position: Q1 2026 in Review

CNB Bank sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 10 shares — an estimated $134 sold.

CNB Bank first reported a position in DFTX in Q3 2021 and held it in 16 quarters. The position peaked at $1K in Q3 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • CNB Bank reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • CNB Bank sold 10 Definium Therapeutics shares in Q1 2026, an estimated $134.
  • CNB Bank first reported a position in Definium Therapeutics in Q3 2021 and held it in 16 quarters.
  • CNB Bank's Definium Therapeutics position peaked at $1K in Q3 2021.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on CNB Bank's 13F filing for Q1 2026, filed 6 May 2026.